Advised a major international drug manufacturer on the legal procedure for notifying the state authorities in the event of failure to comply with the temperature conditions for storage of drugs.

Assisted a Scandinavian manufacturer of surgical instruments in determining the All-Russian Products Classification (OKP) and Commodity Classification for Foreign Trade (TNVED) codes for applying zero rate VAT to the import and sale of medical devices. 

Advised  Dr. Reddy’s Laboratories on trainings on the antimonopoly legislation and legal aspects of medicine promotions; relations between pharmaceutical companies and medical (pharmaceutical) workers.

Advised Smith & Nephew on clinical waste management issues.

For a world-famous pharmaceuticals company, drafted a policy on the Russian representative office's medical research into the company's products.

For Johnson & Johnson, developed a complete product distribution system for Russia, in particular, elaborated provisions on bonuses and discounts, drafted distribution agreements and developed a document management system for the client.

Provided comprehensive support for Oriflame on plant construction projects in the Moscow Region and the construction of service centres in several other Russian regions.

Advised Optima Holding GmbH of Germany on establishing a joint venture in Russia and attracting substantial mezzanine finance to create a centre for hadron/proton therapy.

Provided Kimberly-Clark with comprehensive legal support for a project for building a production facility in the Moscow Region.

Sanofi-Aventis, SGS, Procter&Gamble  - provided advice and due diligence services and acted for the clients in negotiations over office lease projects to accommodate the companies' national headquarters.

Advised Oriflame regarding its Russian and Kazakhstan subsidiaries in connection with its subsequent successful IPO on the Stockholm Stock Exchange.

Advised Agfa Healthcare on a contract with Nuffield Hospitals for provision, integration and support of a group of systems for 40 hospitals and nine mobile x-ray facilities in the UK.

Our Advised a major European cosmetics manufacturer in the £1.926 bln. disposal of its business to another European producer of cosmetics and household goods.

Advised an international pharmaceutical company on all Russia-related legal matters pertaining to sale of the company’s major global business for €4.2 bln.

Acted for Lege Artis. Clinical Research Company in a move to sell its business to a major US investor.

Analysed a major medical company's distribution agreements for compliance with the antitrust regulations.

Advised Teva on development of incentive schemes for business partners.

Advised Kaupthing Singer & Friedlander on its £25.9m facilities to SKN Limited for acquisition of the Lasercare chain of laser clinics, backed by Graphite Capital.

Arranged and held workshops for AstraZeneca employees on antitrust matters and legal aspects of promoting medications.

Advised a leading cosmetics distributor on its business model relying on multi-level direct selling.

Advised a global generics producer on the implications of being included in the register of companies with a market share of more than 35% and developed a strategy to minimise the company’s antitrust risk, including by analysing the client’s internal marketing policy.

Provided advice on opening and closing down regional subdivisions for a major pharmaceutical company.

In a lawsuit contesting a resolution passed by the Chamber for Patent Disputes of Rospatent regarding early termination of legal protection for a confusingly similar trade mark, our lawyers successfully defended the interests of a leading foreign cosmetics manufacturer in the Russian Federation's Supreme Arbitration Court.

Successfully protected the rights of a leading international company in the cosmetics business in court disputes over unlawful use of the client’s trade marks in domain names by Russian cybersquatters.

Provided advice to a major foreign producer of medical devices and equipment and hygiene products on aspects of importing medical devices and equipment, licensing patentable items, trade marks and know-how; conducted seminars for the client’s sales and marketing personnel on advertising medications and medical devices.

Advised Pfizer International LLC on the specifics of liaising with Russian antitrust authorities.

Advised a leading medical equipment producer on major supplies of medical equipment to state medical institutions, the estimated project value being €6 bln.

Advised one of Russia’s biggest perfume and cosmetics retailers on its restructuring programme.

Photo Therapeutics - successfully  negotiated an amicable settlement of a dispute with the client's US distributor of a patented technology solution for skin cancer treatment and anti-ageing light therapy.

Our company advised a world-famous medical equipment company on aspects of lease agreement termination and developed a legal position for use in a relevant dispute.

Lombard Medical. Sale of PolyBioMed to Bayer AG

Medical Solutions: Sale of a key division carrying on the development of software for research in the biomedical market.

Merrill Lynch: Purchase of 100 doctors’ clinics for a total consideration of £150m.

Close Ventures: Management buy out of a medical imaging business from Siemens Medical Solutions USA, Inc.

Intavent Orthofix Limited: Intellectual property issues including research agreements, patent infringement and medical advertising compliance.

InterHealth Canada:

• Successful bid for the provision of clinical services in the Cheshire & Merseyside area under the Government’s Independent Sector Treatment Centre outsourcing programme.
• The Turks & Caicos Islands Hospitals project. Under this $124m project, Interhealth assume long-term responsibility for provision and maintenance of hospital facilities, medical equipment and also the provision of clinical and diagnostic services.
  

MDY Healthcare:

• Establishment of joint venture relating to glucose monitoring system and subsequently unwinding the arrangement.
• Acquisition from 3i Group plc of stakes in UK listed ProStrakan Group plc and SWX listed Santhera Pharmaceuticals Holding AG.
  

NHS Trust:

• The procurement of major medical equipment in conjunction with our advice on the Trust’s £330m PFI project. Additionally, we advised the Trust in relation to the provision of a PACS solution.
• A managed service for radiotherapy equipment. This saw a managed services contract for the provision of three new linear accelerators within the Trust’s newly constructed maternity and oncology development.
  

SurgRx Inc 

• European merger control aspects of its completed acquisition by Ethicon Endo-Surgery Inc, a Johnson & Johnson company.
  

The Royal Bank of Scotland. Financing of the construction and commissioning of privately operated medical research facilities at Keele University. The facilities are involved in the manufacturer and provision of radioactive isotopes for clinical use.

Vidapulse. Proposed licensing agreements, commercialisation and funding in relation to unique woundcare technology.

Lombard Medical. Complex agreements granting US medical giant, Medtronic, licensing and distribution rights for some of Lombard's cutting edge stent-graft implant technology.

The Information Centre. Its innovative health informatics joint venture, Doctor Foster Intelligence, with specialist health informatics provider Dr Foster.

Behalf of Ultradent, liaised with the European Commission and with national authorities in several Member States; influenced legislative proposals before European Parliament; and conducted litigation in national and European courts.

Advised Agfa Healthcare on a contract with Nuffield Hospitals for the provision, integration and support of a group of imaging and radiology systems that will serve the 40 hospitals and nine mobile x-ray facilities of the Nuffield Group across the UK.

Assisted Dentsply and its many subsidiary companies in the protection of its trade mark and brands before the UK and Community Trade Mark Offices. Dentsply is the largest dental manufacturer in the world.

We advised UK pharmaceuticals company on issues relating to rights to confidential information in relation to clinical trials.

US and Australian companies on the regulatory regime for cosmetics, including composition issues, dossier requirements and advertising strategies.

Sure Calm Holdings Limited, a newly formed vehicle backed with equity from Apposite Healthcare Fund, one of the leading healthcare investors in the UK, on three simultaneous acquisitions for an undisclosed sum.

US, Canadian and Australian companies on the regulation of herbal remedies, the different regulatory regimes and how their products would be regulated. Also advised on how to comply with legal requirements for staff training, appointment of a responsible person and the necessary licences.

Lydian Capital Partners on numerous regulatory issues relating to the purchase of registered pharmacies, including the acquisition of  wholesale dealers licenses and manufacturers “special” licenses. Also advised on the provision of nursing services for patients at home under the Care Standards Act 2000.

US and UK companies on regulation of medical devices ranging from devices related to snoring, testing kits, contact lenses and sun cream testing equipment.

American private healthcare company in relation to the regulatory issues and registration process in setting up private treatment centres within the UK.

Tesco in relation to its shares in the Nutricentre including reviewing existing systems for OTC medicines, medical devices, food supplements, cosmetics, herbal remedies and aromatherapy products. Also advised on steps that needed to be taken post completion to ensure ongoing compliance